Antifungal Activity of Streptomyces sp. F204 Against Rhizoctonia Solani and Whole-Genome Sequencing and Metabolomic Analysis.
- 1Department of Pharmacy, The Affiliated Women and Children's Hospital of Ningbo University, Ningbo 315000, China.
- 2School of Pharmacy, Liaoning University of Traditional Chinese Medicine, 77 Shenming Road, Dalian 116600, China.
Abstract
Rhizoctonia solani Kühn is a destructive phytopathogenic fungus with an exceptionally broad host range, infecting over 32 plant families and 188 genera. In this study, we evaluated the antifungal activity of compound 1 from Streptomyces sp. F204 against R. solani, and characterized its genomic features and metabolomic responses under different culture conditions. Based on whole-genome sequences, the highest average nucleotide identity (ANI) and digital DNA-DNA hybridization (dDDH) values between strain F204 and its closest related type strain, Streptomyces puniciscabiei S77, were 91.64% and 45.00%, respectively. Compound 1, the active metabolite isolated from the fermentation broth of Streptomyces sp. F204, was evaluated using the mycelial growth rate method. Genome annotation predicted 8022 genes in strain F204, including protein-coding genes, rRNA genes, and tRNA genes, covering 86.72% of the total genome length. Additionally, antiSMASH 6.0.0 analysis identified 23 biosynthetic gene clusters putatively involved in secondary metabolite production. Comparative metabolomics revealed significantly enriched pathways across different media, including nicotinate and nicotinamide metabolism in Medium No. 2 (B) versus Gause's synthetic medium (A), and pyrimidine metabolism as well as alanine, aspartate, and glutamate metabolism in ISP4 medium (C) versus Gause's synthetic medium (A). On the basis of NMR and mass spectrometry (MS) data, compound 1 is proposed to be a structural analog of daptomycin. It exhibited strong concentration-dependent inhibition of R. solani mycelial growth, achieving 93.07 ± 0.49% inhibition at 200 μg/mL, with an IC₅₀ value of 14.9 μg/mL. These findings indicate that Streptomyces sp. F204 represents a promising source of antifungal metabolites with considerable biosynthetic potential.
Related
- Isolation, Characterization, and Phytotoxic Activity of Streptomyces spp. from Diseased Potato Scab Tubers
- GC-MS identification of a lacthydrazide-class siderophore produced by Streptomyces sp. VITGV100: its antimicrobial activity and molecular docking
- Nanoformulated silymarin enhances antifungal activity against resistant Candida albicans by reducing ergosterol and binding to cell envelope targets
- Design, synthesis, and antifungal activity of (phenylethynyl) phenoxymethyl-1,3-dioxolane triazoles as novel CYP51 inhibitors
- The antibacterial and antifungal activity of honey and propolis from the Australian stingless bee Tetragonula carbonaria
BibTeX
@article{shen2026antifungal,
title = {{Antifungal Activity of Streptomyces sp. F204 Against Rhizoctonia Solani and Whole-Genome Sequencing and Metabolomic Analysis.}},
author = {Longhui Shen and Jinyan Xue and Linyan Zhu},
journal = {Journal of fungi (Basel, Switzerland)},
year = {2026},
month = oct,
doi = {10.3390/jof12100782},
url = {https://europepmc.org/article/MED/42930747},
note = {CC BY},
}
RIS
TY - JOUR
TI - Antifungal Activity of Streptomyces sp. F204 Against Rhizoctonia Solani and Whole-Genome Sequencing and Metabolomic Analysis.
AU - Longhui Shen
AU - Jinyan Xue
AU - Linyan Zhu
PY - 2026
DA - 2026/10/19
JO - Journal of fungi (Basel, Switzerland)
DO - 10.3390/jof12100782
UR - https://europepmc.org/article/MED/42930747
AB - Rhizoctonia solani Kühn is a destructive phytopathogenic fungus with an exceptionally broad host range, infecting over 32 plant families and 188 genera. In this study, we evaluated the antifungal activity of compound 1 from Streptomyces sp. F204 against R. solani, and characterized its genomic features and metabolomic responses under different culture conditions. Based on whole-genome sequences, the highest average nucleotide identity (ANI) and digital DNA-DNA hybridization (dDDH) values between strain F204 and its closest related type strain, Streptomyces puniciscabiei S77, were 91.64% and 45.00%, respectively. Compound 1, the active metabolite isolated from the fermentation broth of Streptomyces sp. F204, was evaluated using the mycelial growth rate method. Genome annotation predicted 8022 genes in strain F204, including protein-coding genes, rRNA genes, and tRNA genes, covering 86.72% of the total genome length. Additionally, antiSMASH 6.0.0 analysis identified 23 biosynthetic gene clusters putatively involved in secondary metabolite production. Comparative metabolomics revealed significantly enriched pathways across different media, including nicotinate and nicotinamide metabolism in Medium No. 2 (B) versus Gause's synthetic medium (A), and pyrimidine metabolism as well as alanine, aspartate, and glutamate metabolism in ISP4 medium (C) versus Gause's synthetic medium (A). On the basis of NMR and mass spectrometry (MS) data, compound 1 is proposed to be a structural analog of daptomycin. It exhibited strong concentration-dependent inhibition of R. solani mycelial growth, achieving 93.07 ± 0.49% inhibition at 200 μg/mL, with an IC₅₀ value of 14.9 μg/mL. These findings indicate that Streptomyces sp. F204 represents a promising source of antifungal metabolites with considerable biosynthetic potential.
SN - 2309-608X
ER -